文献速递血脂与心血管预防冠心病

胆固醇变异性与死亡、心肌梗死及卒中风险:全国性人群研究

Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
PubMed 文献 · Eur Heart J · 2017-01-01

该研究基于韩国全国健康保险系统队列,纳入3 656 648例无心肌梗死和卒中史且接受≥3次健康检查的受试者,中位随访8.3年。结果显示总胆固醇变异性越高,全因死亡、心肌梗死和卒中风险越高,且独立于平均TC水平和降脂药物使用。

要点

  • 总胆固醇变异性与全因死亡、心肌梗死和卒中风险呈线性关联。
  • 最高vs最低CV四分位全因死亡HR 1.26(95%CI 1.24-1.28)。
  • 该关联独立于平均TC水平和降脂药物使用。

核心结论

  • 脂质水平高变异性与不良健康结局相关,提示脂质变异性是普通人群的重要风险因素。

研究设计与样本

  • 基于韩国国民健康保险系统队列的全国性人群研究,纳入3 656 648例无心肌梗死和卒中史且2002至2007年间接受≥3次健康检查的受试者,中位随访8.3年。

主要发现

  • 随访期间发生84 625例死亡(2.3%)、40 991例心肌梗死(1.1%)和42 861例卒中(1.2%)。
  • 总胆固醇变异性越高,全因死亡、心肌梗死和卒中风险越高,呈线性关联。
  • 多变量校正模型中,CV最高vs最低四分位全因死亡HR 1.26(95%CI 1.24-1.28),心肌梗死HR 1.08(95%CI 1.05-1.11),卒中HR 1.11(95%CI 1.08-1.14)。
  • 上述关联独立于平均TC水平和降脂药物使用。
  • 使用SD和VIM建模变异性及多种敏感性分析结果一致。

临床怎么用

  • 在普通人群风险评估中,除平均胆固醇水平外,可关注总胆固醇的访视间变异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: A high visit-to-visit variability in cholesterol levels has been suggested to be an independent predictor of major adverse cardiovascular events in patients with coronary artery disease (CAD). Because whether this notion applies to general population is not known, we aimed to investigate the associations between total cholesterol (TC) variability and the risk of all-cause mortality, myocardial infarction (MI), and stroke. METHODS AND RESULTS: We identified 3 656 648 subjects without a history of MI and stroke who underwent ≥3 health examinations from 2002 to 2007 in the Korean National Health Insurance System cohort. Total cholesterol variability was measured using the coefficient of variation (CV), standard deviation (SD), and variability independent of the mean (VIM). There were 84 625 deaths (2.3%), 40 991 cases of MI (1.1%), and 42 861 cases of stroke (1.2%) during the median follow-up of 8.3 years. There was a linear association between higher TC variability and outcome measures. In the multivariable adjusted model, the hazard ratios and 95% confidence intervals comparing the highest vs. lowest quartiles of CV of TC were 1.26 (1.24-1.28) for all-cause mortality, 1.08 (1.05-1.11) for MI, and 1.11 (1.08-1.14) for stroke, which was independent of mean TC levels and the use of lipid-lowering agents. The results were consistent when modelling variability of TC using SD and VIM, and in various sensitivity analyses. CONCLUSION: High variability in lipid levels is associated with adverse health-related outcomes. These findings suggest that lipid variability is an important risk factor in the general population.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kim MK, Han K, Kim HS, et al. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J. 2017. PMID: 29069458. doi:10.1093/eurheartj/ehx585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。